Area of research
Pharmacology · Biological Psychiatry
Research interest
Research interests include Treatment of Major Depression, Tryptophan and brain disorders, Functional Brain Connectivity Studies, and Stress Responses and Cortisol.
Major depressive disorder shares systemic immune signatures and potential therapeutic targets with inflammatory skin diseases
Molecular dissection of protein complexes isolated from sections of human brain
Spatiotemporal asymmetries on brain energy landscape uncover system entrapment related to depression severity
Structural imaging predictors of ketamine response in treatment-resistant depression: a machine learning approach
Circulating myeloid-derived MMP8 in stress susceptibility and depression
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trial
Immune-Targeted Therapies for Depression
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Social stress induces autoimmune responses against the brain
Stress-related reduction of hippocampal subfield volumes in major depressive disorder: A 7-Tesla study
Peripheral immune-derived matrix metalloproteinase promotes stress susceptibility
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators
Beyond the neuron: Role of non-neuronal cells in stress disorders
The long noncoding RNA FEDORA is a cell type– and sex-specific regulator of depression
Blood miR-144-3p: a novel diagnostic and therapeutic tool for depression
The Potential of KCNQ Potassium Channel Openers as Novel Antidepressants
Exaggerated amygdala response to threat and association with immune hyperactivity in depression
The Ketamine Side Effect Tool (KSET): A comprehensive measurement-based safety tool for ketamine treatment in psychiatry
Ventral tegmental area integrity measured with high-resolution 7-Tesla MRI relates to motivation across depression and anxiety diagnoses
Social stress induces autoimmune responses against the brain to promote stress susceptibility
Moral distress in frontline healthcare workers in the initial epicenter of the COVID‐19 pandemic in the United States: Relationship to PTSD symptoms, burnout, and psychosocial functioning
Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia
Vortioxetine Versus Placebo for Major Depressive Disorder
The Long Noncoding RNA FEDORA is a Cell-Type- and Sex-Specific Regulator of Depression
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia
Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance
Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)
Ketamine normalizes subgenual cingulate cortex hyper-activity in depression